Adoptive immunotherapy of disseminated malignancies (original) (raw)

References

  1. Alexander P., Derham S, Hootor J: On the nature of the antigen (HO-SAL) responsible for protection of August rats against a syngeneic leukemia following immunization with AgB-identical allogeneic cells. Transplant. Proc.12, 152, 1980.
    PubMed CAS Google Scholar
  2. Altman A, Katz D. H.: The induction of autoreactive T lymphocytes by allogeneic effect factor (AEF): relevance to normal pathways of lymphocyte differentiation. Immunol. Rev_51_, 3, 1980.
    Article PubMed CAS Google Scholar
  3. Bach M. L., Bach F. H., Zarling J. M.: Pool-priming: a means of generating T lymphocytes cytotoxic to tumor or virus-infected cells.—Lancet_i_, 20, 1978.
    Article Google Scholar
  4. Barnes D. W. H., Corp M. J., Loutit J. F., Neal F. E.: Treatment of murine leukaemia with x-rays and homologous bone marrow.—Brit. med. J.ii, 626, 1956.
    Google Scholar
  5. Bear R. H., Roholt O. A., Pressman D: Allosensitization protects against lethal challenge with a syngeneic mouse lymphoma.—Transplant. Proc.12, 150, 1980.
    PubMed CAS Google Scholar
  6. Bekesi J. G., Roboz J. P., Zimmerman E., Holland J. F.: Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy or interferon.—Cancer Res.36, 631, 1976.
    PubMed CAS Google Scholar
  7. Blume K. G., Beutler E., Bross K. J., Chillar R. K., Ellington D. B., Fahey J. L., Farbstein W. J., Forman S. J., Schmidt G. M., Scott E. P., Spruce W. E., Turner M. A., Wolf J. L.: Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia.—New Engl. J. Med.302, 1041, 1980.
    PubMed CAS Google Scholar
  8. Bodmer W. F.: New genetic model for allelism at histocompatibility and other complex loci: polymorphism for control of gene expression.—Transplant. Proc.4, 1471, 1973.
    Google Scholar
  9. Bonavida B., Roman J. M., Hutchinson I. V.: Inappropriate alloantigen-like specificities detected on reticulum cell sarcomas of SJL/J mice: characterization and biologic role. Transplant. Proc.12, 59, 1980.
    PubMed CAS Google Scholar
  10. Bonavida B., Wilbur S. M., Marcelli O.: Surface expression of alien hybrid IE/C antigens on the reticulum cell sarcoma of SJL/J mice.—Transplant. Proc.13, 1833, 1981.
    PubMed CAS Google Scholar
  11. Boranic M.: Transient graft-versus-host reaction in the treatment of leukemia in mice. J. nat. Cancer Inst.41, 421, 1968.
    PubMed CAS Google Scholar
  12. Bortin M. M., Gale R. P., Kay H. E. M., Rimm A. A.: Bone marrow transplantation for acute myelogenous leukemia: factors associated with early mortality.—J. Amer. med. Ass.249, 1166, 1983.
    Article CAS Google Scholar
  13. Bortin M. M., Rimm A. A., Rose W. C., Saltzstein E. C.: Graft-versus-leukemia. V. Absence of antileukemic effect using allogeneic, H-2-identical immunocompetent cells.—Transplantation_18_, 280, 1974.
    Article PubMed CAS Google Scholar
  14. Bortin M. M., Rimm A. A., Saltzstein E. C.: Graft versus leukemia: quantification of adoptive immunotherapy in murine leukemia.—Science_179_, 811, 1973.
    Article PubMed CAS Google Scholar
  15. Bortin M. M., Rose W. C., Truitt R. L., Rimm A. A., Saltzstein E. C., Rodey G. E.: Graft versus leukemia. VI. Adoptive immunotherapy in combination with chemoradiotherapy for spontaneous leukemia-lymphoma in AKR mice.—J. nat. Cancer Inst.55, 1227 1975.
    PubMed CAS Google Scholar
  16. Bortin M. M., Truitt R. L (Eds): Alien, histocompatibility antigens in cancer: biological significance and potential usefulness in prevention, diagnosis and treatment. Grune and Stratton, New York, 1980; vol. 1.
    Google Scholar
  17. Bortin M. M., Truitt R. L. (Eds): Alien histocompatibility antigens in cancer: biological significance and potential usefulness in prevention, diagnosis and treatment. Grune and stratton, New York, 1980; vol. 2.
    Google Scholar
  18. Bortin M. M., Truitt R. L., Rimm A. A.: Nonspecific adoptive immunotherapy of T cell acute lymphoblastic leukemia in AKR mice: a model for the treatment of T cell leukemia in man. In:Waters H. (Ed.) The handbook of cancer immunology Vol. 5: Immunotherapy Garland Publ. Co., New York, 1978; p. 403.
    Google Scholar
  19. Bortin M. M., Truitt R. L., Rimm A. A., Bach F. H.: Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity.—Nature (Lond.)281, 490, 1979.
    Article CAS Google Scholar
  20. Bortin M. M., Truitt R. L., Shih C. Y., Rimm A. A.: Graft-versus-leukemia: allosensitization of MHC compatible donors induces antileukemic reactivity without amplification of antihost reactivity. In:Thierfelder S., Rodt H., Kolb H. J. (Eds) Immunobiology of bone marrow transplantation. Springer-Verlag, New York, 1980; p. 31.
    Google Scholar
  21. Bortin M. M., Truitt R. L., Shih C. Y., Rimm A. A.: Graft-versus-leukemia. X. Induction of reactivity against murine leukemia in MHC compatible donors. In:Okunewick J. P., Meredith R. F. (Eds). Graft-versus-leukemia in man and animal models. CRC Press, Boca Raton, Florida, 1981; p. 139.
    Google Scholar
  22. Cheever M. A., Greenberg P. D., Fefer A.: Therapy of leukemia by nonimmune syngeneic spleen cells.—J. Immunol.124, 2137, 1980.
    PubMed CAS Google Scholar
  23. Chester S. J., Esparza A. R., Albala M. M.: Graft-versus-leukemia without fatal graft-versus host disease in AKR mice.—Cancer Res.35, 637, 1975.
    PubMed CAS Google Scholar
  24. Demant P., Festenstein H.: Workshop on H-2 antigens. London, England, April 20-May 3, 1979.—Immunogenetics_9_, 305, 1979.
    Article Google Scholar
  25. Einstein A. B. Jr.,Cheever M. A., Fefer A.: Use of dimethylmyleran in adoptive chemo immunotherapy of two murine leukemias.—J. nat. Cancer Inst.56, 609, 1976.
    PubMed Google Scholar
  26. Emerson S. G., Cone R. E.: Absorption of shed I-Ak and H-2Kk antigens by lymphoid cells. Transplantation_33_, 36, 1982.
    Article PubMed CAS Google Scholar
  27. Fass L., Fefer A.: Studies of adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.—Cancer Res.32, 2427, 1972.
    PubMed CAS Google Scholar
  28. Fefer A., Goldstein A. L. (Eds): The potential role of T cells in cancer therapy. Raven Press, New York, 1982.
    Google Scholar
  29. Festenstein H., Schmidt W.: Variation in MHC antigenic profiles of tumor cells and its biological effects.—Immunol. Rev.60, 85, 1981.
    Article PubMed CAS Google Scholar
  30. Festenstein H., Schmidt W., Testorelli C., Marelli O., Simpson S.: Biological affects of the altered MHC profile on the K36 tumor, a spontaneous leukemia of AKR.—Transplant. Proc.12, 25, 1980.
    PubMed CAS Google Scholar
  31. Finke Y. M., Fyfe D. A., Del Villano B. C., Butler G. H., Ponzio N. M.: Characterization of ‘foreign’ alloantigen-like specificities on a murine lymphoma cell line, Transplant. Proc.12, 53, 1980.
    PubMed CAS Google Scholar
  32. Flaherty L., Rinchik E.: No evidence for foreign H-2 specificities on the EL-4 mouse lymphoma—Nature (Lond.)273, 52, 1978.
    Article CAS Google Scholar
  33. Frei E. IIISchabel F. M. Jr.,Goldin A.: Comparative chemotherapy of AKR lymphoma and human hematological neoplasia—Cancer Res.34, 184, 1974.
    PubMed CAS Google Scholar
  34. Gale R. P., Kay H. E. M., Rimm A. A., Bortin M. M.: Bone marrow transplantation for acute myelogenous leukemia in first remission—Lancet_ii_, 1006, 1982.
    Article Google Scholar
  35. Garrido F., Schirrmacher V., Festenstein H.: Studies on H-2 specificities on mouse tumor cells by a new microradioassay—J. Immunogenet.4, 15, 1977.
    Article PubMed CAS Google Scholar
  36. Glasebrook A. L., Fitch F. W.: Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines—J. exp. Med.151, 876, 1979.
    Article Google Scholar
  37. Gotohda E., Kawamura T., Yamada Y., Hosokawa M., Kodama T., Kobayashi H.: Therapeutic effect dependent on timing of combination treatment with chemotherapy and allogeneic lymphoid cell transfer in rats—Transplant. Proc.12, 147, 1980.
    PubMed CAS Google Scholar
  38. Greene M. J., Perry L. L.: The relationship of alloreactivity to syngeneic tumor immunity— Transplant. Proc.12, 80, 1980.
    PubMed CAS Google Scholar
  39. Herberman R. B., Nunn M. E., Holden H. T., Staal S., Djeu J. Y.: Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells— Int. J. Cancer_19_, 555, 1977.
    Article PubMed CAS Google Scholar
  40. Indiveri F., Wilson B. S., Pellegrino M. A., Ferrone S.: Detection of human histocompatibility (HLA) antigens with an indirect rosette microassay—J. immunol. Meth.29, 101, 1979.
    Article CAS Google Scholar
  41. Indiveri F., Wilson B. S., Pellegrino M. A., Ferrone S.: Production and characterization of DR xenoantisera: use for detection of serum DR antigens—J. Immunol.122, 1967, 1979.
    PubMed Google Scholar
  42. Invernizzi G., Parmiani G.: Tumor-associated transplantation antigens of chemically induced sarcomata cross-reacting with allogeneic histocompatibility antigens—Nature (Lond.)254, 713, 1975.
    Article CAS Google Scholar
  43. Kahan B., Auerbach R., Alter B. J., Bach F. H.: Histocompatibility and isoenzyme differences in commercially supplied ‘Balb/c’ mice—Science_217_, 379, 1982.
    Article PubMed CAS Google Scholar
  44. Katz D. H., Paul W. E., Goidl E. A., Benacerraf B.: Carrier function in anti-hapten antibody responses. III. Stimulation of antibody synthesis and facilitation of hapten-specific secondary antibody responses by graft-versus-host reactions—J. exp. Med.133, 169, 1971.
    Article PubMed CAS Google Scholar
  45. Klein P. A.: Problems with and approaches to specificity in the serologic measurement of histocompatibility and tumor-associated antigens on tumor cell surfaces—Transplant. Proc.12, 16, 1980.
    PubMed CAS Google Scholar
  46. Kobayashi H., Hosokawa M.: Further evidence for antitumor resistance in WKA rats immunized with allogeneic cells—Transplant. Proc.13, 1922, 1981.
    PubMed CAS Google Scholar
  47. Kobayashi H., Hosokawa M., Oikawa T.: Transplantation immunity to syngeneic tumors in WKA rats immunized with allogeneic cells—Transplant. Proc.12, 156, 1980.
    PubMed CAS Google Scholar
  48. Lannin D. R., Yu S., McKhann C. F.: H-2 restriction of the T cell response to chemically induced tumors: evidence from F1→ parent chimeras—J. Immunol.128, 263, 1982.
    PubMed CAS Google Scholar
  49. Law L. W., Dubois C., Rogers M. J., Appella E., Pierotti M. A., Parmiani G.: Tumor rejection activity of antigens isolated from the membranes of a methylcholanthrene-induced sarcoma, C-1, bearing alien H-2 antigens—Transplant. Proc.12, 46, 1980.
    PubMed CAS Google Scholar
  50. LeFeber W. P., Truitt R. L., Rose W. C., Bortin M. M.: Graft-versus-leukemia, donor selection for adoptive immunotherapy in mice In:Baum S., Ledney G. D. (Eds): Experimental Hematology Today—1977. Springer-Verlag, New York, 1977; p. 239.
    Google Scholar
  51. Lorber M. I., Loken M. R., Stall A. M., Fitch F. W.: I-A antigens on cloned alloreactive murine T lymphocytes are acquired passively—J. Immunol.123, 2798, 1982.
    Google Scholar
  52. Martin W. J., Esber E., Cotton W. G., Rice J. M.: Derepression of alloantigens in malignancy, Evidence for tumor susceptibility alloantigens and for possible self-reactivity of lymphoid cells active in microcytotoxicity assay—Brit. J. Cancer_28_, 48, 1977.
    Google Scholar
  53. Martin W. J., Gipson T. G., Rice J. M.: H-2a-associated alloantigens expressed by several transplacentally-induced lung tumors of C3Hf mice—Nature (Lond.)265, 738, 1977.
    Article CAS Google Scholar
  54. Mathé G., Schwarzenberg L., DeVries M. J., Amiel J. L., Cattan A., Schneider M., Binet J. L., Tubiana M., Lalanne C., Schwarzmann V., Nordmann R.: Les divers aspects du syndrome secondaire compliquant les transfusions allogéniques de moelle osseuse ou de leucocytes chez des sujets atteints d'hémopathies malignes—Europ. J. Cancer_1_, 75, 1965.
    Google Scholar
  55. McAlack R. F.: Normal HLA phenotypes and neo-HLA-like antigens on cultured human neuroblastoma—Transplant. Proc.12, 107, 1980.
    PubMed CAS Google Scholar
  56. McIntyre R., Gale R. P.: Relationship between graft-versus-leukemia and graft-versus-host in man, UCLA experience. In:Okunewick J. P., Meredith R. F. (Eds): Graft-versus-leukemia in man and animal models. CRC Press, Boca Raton, Florida, 1981; p. 1.
    Google Scholar
  57. Meschini A., Invernizzi G., Parmiani G.: Expression of alien H-2 specificities on a chemically induced Balb/c fibrosarcoma—Int. J. Cancer_20_, 271, 1977.
    Article PubMed CAS Google Scholar
  58. Nathanson S. D., Pellegrino M. A., Ferrone S.: Serum HLA-A and B alloantigens in patients with malignant melanoma—Transplant. Proc.13, 1939, 1981.
    PubMed CAS Google Scholar
  59. Okunewick J. P., Meredith R. F. (Eds): Graft-versus-leukemia in man and animal models. CRC Press, Boca Raton, Florida, 1981.
    Google Scholar
  60. Paciucci P. A., MacPhail S., Zarling J. M., Bach F. H.: Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells—J. Immunol.124, 370, 1980.
    PubMed CAS Google Scholar
  61. Parmiani G.: Foreign histocompatibility determinants as tumor-associated transplantation antigens of chemically induced murine fibrosarcomas. In:Ferrara G. B. (Ed.): HLA system new aspects. Elsevier/North-Holland Biomedical Press, Amsterdam, 1977; p. 45.
    Google Scholar
  62. Parmiani G.: Lack of identity between TSTA and alien antigens of methylcholanthrene-induced murine sarcomas—Transplant. Proc.12, 50, 1980.
    PubMed CAS Google Scholar
  63. Parmiani G., Ballinari D., Sensi M. L.: Tumor associated alien alloantigens of Balb/c tumors encoded by the MHC and by non-H-2 genes: a histogenetic study—J. Immunol.124, 662, 1980.
    PubMed CAS Google Scholar
  64. Parmiani G., Fossati G., Della Porta G.: The undefined relationship between tumor antigens and histocompatibility antigens on cancer cells—La Ricerca Clin. Lab.10, 481, 1980.
    CAS Google Scholar
  65. Parmiani G., Invernizzi G.: Ahen histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I.In vivo studies—Int. J. Cancer_16_, 756, 1975.
    Article PubMed CAS Google Scholar
  66. Pellegrino M. A., Weaver J. F., Nelson-Rees W. A., Ferrone S.: Ia-like and HLA-A, B antigens on tumor cells in long-term culture—Transplant. Proc.13, 1935, 1981.
    PubMed CAS Google Scholar
  67. Plata F., Lilly F.: Viral specificity of H-2 restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus—J. exp. Med.150, 1174, 1979.
    Article PubMed CAS Google Scholar
  68. Plata F., Tilkin A., Levy J., Lilly F.: Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes—J. exp. Med.154, 1795, 1981.
    Article PubMed CAS Google Scholar
  69. Pollack M. S.: The detection of weak allogeneic stimulation by DR-positive tumor cell lines—Transplant. Proc.13, 1947, 1981.
    PubMed CAS Google Scholar
  70. Powles R. L., Morgenstern G., Clink H. M., Hedley D., Bandini G., Lumley H., Watson J. G., Lawson D., Spence D., Barrett A., Jameson B., Lawler S., Kay H. E. M., McElwain T. J.: The place of bone-marrow transplantation in acute myelogenous leukaemia—Lancet_i_, 1047, 1980.
    Article Google Scholar
  71. Robinson P. J., Sege K., Altevogt P., Peterson P. A., Lundin L., Garrido F., Schirrmacher V.: Unexpected H-2 antigen expression by mouse tumor cells, a cautionary note— Immunogenetics_13_, 261, 1981.
    Article PubMed CAS Google Scholar
  72. Rodey G. E., Bortin M. M., Bach F. H., Rimm A. A.: Mixed leukocyte culture reactivity and chronic graft-versus-host reactions (secondary disease) between allogeneic H-2a mouse strains—Transplantation_17_, 84, 1974.
    Article PubMed CAS Google Scholar
  73. Rogers M. J., Appella E., Pierotti M. A., Invernizzi G., Parmiani G.: Biochemical characterization of alien H-2 antigens expressed on a methylcholanthrene-induced tumor— Proc. nat. Acad. Sci. (Wash.)76, 1415, 1979.
    Article CAS Google Scholar
  74. Rocers M. J., Carbone G., Ballinari D., Cattaneo M., Parmiani G.: Biochemical characterization of the anomalous reaction of anti-H-a1 origin—Transplant. Proc.13, 1774, 1981.
    Google Scholar
  75. Rollinghoff M., Wagner H.: The allogeneic effect: M-locus differences substitute for differences in the H-2 major histocompatibility complex—J. Immunol.114, 1329, 1975.
    PubMed CAS Google Scholar
  76. Rosenberg S. A., Terry W. D.: Passive immunotherapy of cancer in animals and man— Advanc. Cancer Res.25, 323, 1977.
    Article CAS Google Scholar
  77. Schmidt W., Festenstein H.: Immunochemical studies on gains and losses on K36— Immunogenetics_9_, 310, 1979.
    Google Scholar
  78. Schmidt W., Festenstein H., Atfield G.: Serologic and immunochemical studies of the cell membrane alloantigens of K36, an AKR spontaneous leukemia—Transplant. Proc.12, 29, 1980.
    PubMed CAS Google Scholar
  79. Sendo F., Seiji S., Watabe S., Fuyama S., Arai S.: Cytotoxicity induced by inflammatory cells stimulated with allosensitized lymphocytes—Transplant. Proc.12, 160, 1980.
    PubMed CAS Google Scholar
  80. Sensi M., Carbone G., Parmiani G.: Original H-ad and alien H-ak-like antigens of a Balb/c fibrosarcoma as defined by_in vitro_ and_in vivo_ studies of cell-mediated immunity—Europ. J. Immunol.10, 671, 1980.
    Article CAS Google Scholar
  81. Sharrow S. G., Mathieson B. J., Singer A.: Cell surface appearance of unexpected host MHC determinants on thymocytes from radiation bone marrow chimeras—J. Immunol.126, 1327, 1981.
    PubMed CAS Google Scholar
  82. Shih C. Y., Truitt R. L., Bortin M. M.: Growth of T-lymphoblastic leukemia cells_in vitro_ using T cell growth factor—Exp. Hemat.8, 120, 1980.
    Google Scholar
  83. Silver J., Hood L.: Prelirninary amino acid sequences of transplantation antigens: genetic and evolutionary implications—Contemp. Top. molec. Immunol.5, 35, 1976.
    CAS Google Scholar
  84. Simonsen M.: Graft versus host reactions, their natural history and applicability as tools of research—Progr. Allergy_6_, 349, 1962.
    Article CAS Google Scholar
  85. Strausser J. L., Mazumder A., Grimm E. A., Lotze M. T., Rosenberg S. A.: Lysis of human solid tumors by autologous cells sensitized_in vitro_ to alloantigens—J. Immunol.127 266, 1981.
    PubMed CAS Google Scholar
  86. Thomas E. D., Buckner C. D., Clift R. A., Fefer A., Johnson F. L., Neiman P. E., Sale G. E., Sanders J. E., Singer J. W., Shulman H., Storb R., Weiden P. L.: Marrow transplantation for acute nonlymphoblastic leukemia in first remission—New Engl. J. Med.301, 597, 1979.
    PubMed CAS Google Scholar
  87. Truitt R.L.: Use of decontamination and a protected environment to prevent secondary disease following adoptive immunotherapy of acute leukemia in mice. In:Baum S. J., Ledney G. D. (Eds): Experimental Hematology Today—1978. Springer-Verlag, New York, 1978; p. 195.
    Google Scholar
  88. Truitt R. L., Bortin M. M.: Adoptive immunotherapy of malignant disease: model systems and their relevance to human disease. In:Slavin S. (Ed.): Clinical and experimental transplantation: present status, future directions. Elsevier/North-Holland Biomedical Press, Amsterdam, 1982. (In press).
    Google Scholar
  89. Truitt R. L., Bortin M. M., Rimm A. A.: Alloimmunization: induction of antileukemic reactivity without modification of anti-host reactivity in H-2 compatible mice—Transplant. Proc.12, 143, 1980.
    PubMed CAS Google Scholar
  90. Truitt R. L., Shih C. Y., Rimm A. A., Tempelis L. D., Bortin M. M.: Alloimmunization and adoptive immunotherapy of leukernia—Transplant. Proc.13, 1910, 1981.
    PubMed CAS Google Scholar
  91. Truitt R. L., Shih C.-Y., Rimm A. A., Tempelis L. D., Bortin M. M.: Alloimmunization of H-2 compatible donors for adoptive immunotherapy of leukemia: role of H-2, M1s and non-H-2 antigens. In:Fefer A., Goldstein A. L. (Eds): The potential role of T cells in cancer therapy. Raven Press, New York, 1982; p. 21.
    Google Scholar
  92. Valeriote F. A., Bruce W. R., Meeker B. E.: Synergistic action of cyclophosphamide and 1,3 bis(2-chloroethyl)-1-nitrosourea on a transplanted murine lymphoma—J. nat. Cancer Inst.40, 935, 1968.
    PubMed CAS Google Scholar
  93. Weiden P. L., Flournoy N., Sanders J. E., Sullivan K. M., Thomas E. D.: Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation—Transplant. Proc.13, 248, 1981.
    PubMed CAS Google Scholar
  94. Weiden P. L., Sullivan K. M., Flournoy N., Storb B., Thomas E. D.: Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation—New Engl. J. Med.304, 1529, 1981.
    PubMed CAS Google Scholar
  95. Woda B. A., Yguerabide J., Feldman J. D.: Mobility and density of AgB ‘Ia’ and Fc receptors on the surface of lymphocytes from young and old rats—J. Immunol.123, 2161, 1979.
    PubMed CAS Google Scholar
  96. Zarling J. M., Bach F. H.: Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines—J. exp. Med.147, 1334, 1978.
    Article PubMed CAS Google Scholar
  97. Zarling J. M., Robins H. T., Raich P. C., Bach F. H., Bach M. L.: Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells—Nature (Lond.)274, 269, 1978.
    Article CAS Google Scholar
  98. Zielinski C. C., Waters D. L., Datta S. K., Waksal S. D.: Analysis of intrathymic differentiation patterns during the course of AKR leukemogenesis—Cell. Immunol.59, 355, 1981.
    Article PubMed CAS Google Scholar

Download references